Counterparty risk, charges and complexity have conspired to give structured products a bad name, but there are signs advisers are turning to them once again.
The death knell for many structured products was sounded on 27 October 2009. That was the day the FSA announced “tough” action to help investors who received unsuitable advice or misleading literature when they bought a structured product backed by Lehman Brothers, which had collapsed a year earlier. It was the first time some investors had heard of counterparty risk and, for some of their advisers, it was reason enough to stop recommending them altogether. But advisers were already wary of the products. Some believed the commission offered on some structures was too high – an aver...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes